BVXV
$1.70
Biondvax Pharma ADR
BVXV
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  $0.00
Revenue:  N/A
Monday
Aug 14
9:15 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when BVXV reports earnings?
Beat
Meet
Miss

Where is BVXV's stock price going from here?
Up
Flat
Down
Stock chart of BVXV
Analysts
Summary of analysts' recommendations for BVXV
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
BiondVax Pharmaceuticals Ltd. is a biopharmaceutical company. The company's product includes Multimeric-001 universal flu vaccine which provides multi-season and multi-strain protection against human influenza virus strains. BiondVax Pharmaceuticals Ltd. is based in Ness Ziona, Israel.
›